Create a free account to get access to stock details and our dividend tracker
We won't send you any spam and we don't want a credit card.
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in clinical trials. Its drug candidates are in development for the treatment of solid tumors, leukemia, B-cell malignancies, lymphomas, and myelodysplastic syndrome.
Vincerx Pharma, Inc. is based in Palo Alto, California.
Based on sector and market capitalization